Main menu

Nanopore sequencing for clinical genetics: From critical care to complex genomic signatures

  • Published on:

Debarshi Mustafi (Seattle Children’s Hospital, USA) discusses how the capabilities of nanopore sequencing could translate into clinical insight in the future. Using examples from inherited retinal disease and retinoblastoma, he will illustrate how long nanopore reads can resolve difficult structural and noncoding variants, phase haplotypes, determine parental origin, and generate methylation data alongside genetic information.

This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Debarshi Mustafi (Seattle Children's Hospital)

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

知识产权 Cookie 政策 企业报告 隐私政策 条件条款 Modern slavery policy 前瞻性陈述

关于 Oxford Nanopore

联系我们 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditation
Chinese flag